Key Highlights

Risk & Performance

Pipeline Risk Assessment

Based on historical performance

Low Risk

Score: 25/100

Failure Rate

0.0%

0 terminated/withdrawn out of 7 trials

Success Rate

100.0%

+13.5% vs industry average

Late-Stage Pipeline

29%

2 trials in Phase 3/4

Results Transparency

50%

1 of 2 completed trials have results

Key Signals

2 recruiting1 with results

Enrollment Performance

Analytics

N/A

2(50.0%)

Phase 4

2(50.0%)

4Total

N/A(2)

Phase 4(2)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (7)

Showing 7 of 7 trials

NCT07537517Recruiting

Evaluation of the BMPR2-Activin Signaling Pathway in Group II Pulmonary Hypertension.

Role: collaborator

NCT07440186Not ApplicableNot Yet Recruiting

Exploratory Clinical Research for the Evaluation of Human GMP (Good Manufacturing Practice) Collagen Implants (Humabiologics) in the Treatment of Corneal Melting (RCJ-COL3D-MC-01-2026)

Role: collaborator

NCT07422090Recruiting

Preventing Suicide With Digital Phenotyping and Pharmacogenetics-Based Interventions

Role: collaborator

NCT06478745Enrolling By Invitation

Trajectories and Experiences of People With Multimorbidity in Spain (LOXO-MULTIPAP) Project: a Mixed Methods Study

Role: collaborator

NCT02033174Not ApplicableCompleted

Effects of Alcoholic Beverages in Pro-inflammatory and Antioxidant Profile After an Oral Fat Diet

Role: lead

NCT02526862Phase 4Completed

Prevention of Pressure Ulcers in Patients Under Non-Invasive Mechanical Ventilation

Role: collaborator

NCT01834872Phase 4Unknown

Safety and Feasibility of Arrhythmia Ablation Using the Amigo Remote Robotic System as Compared With Manual Ablation

Role: lead

All 7 trials loaded